[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Top XX Stocks in Healthcare by Market Cap
| Stock | Market Cap |
|---|---|
| Eli Lilly and Company (LLY) | $XXXXXXXXXXXXXXX |
| Johnson & Johnson (JNJ) | $XXXXXXXXXXXXXXX |
| AbbVie Inc (ABBV) | $XXXXXXXXXXXXXXX |
| UnitedHealth Group (UNH) | $XXXXXXXXXXXXXXX |
| AstraZeneca PLC (AZN) | $XXXXXXXXXXXXXXX |
| Novartis AG (NVS) | $XXXXXXXXXXXXXXX |
| Merck & Co., Inc. (MRK) | $XXXXXXXXXXXXXXX |
| Novo-Nordisk (NVO) | $XXXXXXXXXXXXXXX |
| Abbott Laboratories (ABT) | $XXXXXXXXXXXXXXX |
| Thermo Fisher Scientific Inc. (TMO) | $XXXXXXXXXXXXXXX |
Johnson & Johnson
Johnson & Johnson Johnson & Johnson ordered to pay $40m in baby powder cancer lawsuit, while also receiving FDA approval for its prostate cancer therapy, Akeega.
Price: $XXXXXX
Despite reaching a 52-week high, JNJ's stock is experiencing downward pressure due to ongoing lawsuits related to baby powder and Tylenol, which are overshadowing positive advancements in robotics and drug research.
24-Hour: XXXX% 7-Day: XXXX% 30-Day: XXXX%
1-Year High: $XXXXXX on 2025-12-12
1-Year Low: $XXXXXX on 2025-01-11
AltRank: XXX
Johnson & Johnson (JNJ) is currently AltRank #478 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX +301
X Month: XXX +192
X Months: XXX -XXX
X Year: XXX +113
1-Year High: XXXXX on 2025-07-02
1-Year Low: X on 2025-01-13
Galaxy Score: XXXXX
Current Value: XXXXX
Daily Average: XX
X Week: XX +7
X Month: XX -X
X Months: XX -X
X Year: XX +11
1-Year High: XX on 2025-11-10
1-Year Low: XX on 2025-01-03
Engagements: XXXXXXX (24h)
Current Value: XXXXXXX
Daily Average: XXXXXXX
X Week: XXXXXXXXXX +824%
X Month: XXXXXXXXXX -XX%
X Months: XXXXXXXXXXX +41%
X Year: XXXXXXXXXXX -XX%
1-Year High: XXXXXXXXXX on 2025-11-11
1-Year Low: XXXXXX on 2025-08-31
Engagements by network (24h): News: XXX Reddit: XXX TikTok: XXXXXX X: XXXXXX YouTube: XXXXXX
Mentions: XXX (24h)
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX +36%
X Month: XXXXXX -XX%
X Months: XXXXXXX +247%
X Year: XXXXXXX +109%
1-Year High: XXXXX on 2025-10-31
1-Year Low: XXX on 2025-12-07
Mentions by network (24h): News: XX Reddit: XX TikTok: XXX X: XXXXX YouTube: XXX
Creators: XXX (24h)
XXX unique social accounts have posts mentioning Johnson & Johnson (JNJ) in the last XX hours which is down XX% from XXX in the previous XX hours
Daily Average: XXX
X Week: XXXXX +53%
X Month: XXXXX -XX%
X Months: XXXXXX +416%
X Year: XXXXXX +295%
1-Year High: XXXXX on 2025-10-31
1-Year Low: XXX on 2025-06-08
The most influential creators that mention Johnson & Johnson in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @semodough | X | XXXXXX | X | XXXXXX |
| @doepke_michel | X | XXXXX | XX | XXXXXX |
| @ntvglobal | X | XXXXXXX | X | XXXXX |
| @seedy19tron | X | XXXXX | X | XXXXX |
| @ppatour | X | XXXXXXX | XX | XXXXX |
| @Quantumup1 | X | XXXXX | X | XXXXX |
| @eye7chaudharyeyecentre | X | XXXXXXXXX | X | XXXXX |
| @destinationinternship | X | XXXXXX | X | XXXXX |
| @equitydd | X | XXXXX | X | XXXXX |
| @jnjmedtechsurgery | XX | XXXXXXX | X | XXXXX |
Sentiment: XX%
Current Value: XX%
Daily Average: XX%
X Week: XX% +5%
X Month: XX% -XX%
X Months: XX% +8%
X Year: XX% +10%
1-Year High: XXX% on 2025-11-11
1-Year Low: XX% on 2025-09-26
Most Supportive Themes:
- Robotics Development: (1%) Johnson & Johnson is advancing its healthcare robotics development using NVIDIA's Isaac platform.
- Oral Drug Development: (1%) Johnson & Johnson is developing oral drugs, with positive results from the Phase 2b ANTHEM-UC study.
Most Critical Themes:
- Talc Baby Powder Lawsuits: (30%) Johnson & Johnson faces renewed scrutiny and lawsuits over its baby powder products, with allegations of cancer links.
- Tylenol Autism Risk Lawsuit: (30%) Texas AG is suing Johnson & Johnson and Kenvue, alleging deceptive marketing of Tylenol and concealment of autism risks in unborn children.
Social Dominance: XXXXX%
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.079%
X Month: XXXXX% -XXXXX%
X Months: XXXXX% +0.117%
X Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-10-31
1-Year Low: XXXXX% on 2025-08-02
Market Dominance: XXXXX%
Current Value: XXXXX%
Daily Average: XX%
1-Year High: XX% on 2025-11-23
1-Year Low: XXXXX% on 2025-12-13
Market Cap: $XXXXXXXXXXXXXXX
Current Value: $XXXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXXX +$4.90%
X Month: $XXXXXXXXXXXXXXX +$8.40%
X Months: $XXXXXXXXXXXXXXX +$36%
X Year: $XXXXXXXXXXXXXXX +$45%
1-Year High: $XXXXXXXXXXXXXXX on 2025-12-12
1-Year Low: $XXXXXXXXXXXXXXX on 2025-01-10
Eli Lilly and Company
Eli Lilly and Company Eli Lilly's new weight loss drug, retatrutide, shows promising results in late-stage trials, potentially offering significant weight reduction. The company is also expanding manufacturing with a new $X billion plant in Alabama.
Price: $XXXXXXXX
Eli Lilly's stock is experiencing an upward trend supported by strong drug performance, particularly in the weight loss sector, and AI partnerships, with recent social media discussions indicating potential buyouts and ongoing competition influencing short-term price movements.
24-Hour: XXXX% 7-Day: XXXX% 30-Day: XXXX%
1-Year High: $XXXXXXXX on 2025-11-25
1-Year Low: $XXXXXX on 2025-08-08
AltRank: XXX
Eli Lilly and Company (LLY) is currently AltRank #338 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX +285
X Month: XXX +239
X Months: XXX -XXX
X Year: XXX -XXX
1-Year High: XXXXX on 2025-07-17
1-Year Low: X on 2025-04-19
Galaxy Score: XXXXX
Current Value: XXXXX
Daily Average: XX
X Week: XX +22
X Month: XX +14
X Months: XX -X
X Year: XX +48
1-Year High: XX on 2025-03-24
1-Year Low: XX on 2024-12-25
Engagements: XXXXXXX (24h)
Current Value: XXXXXXX
Daily Average: XXXXXXX
X Week: XXXXXXXXX +6.30%
X Month: XXXXXXXXXX -XX%
X Months: XXXXXXXXXXX +143%
X Year: XXXXXXXXXXX +51%
1-Year High: XXXXXXXXXX on 2025-11-11
1-Year Low: XXXXXXX on 2025-03-16
Engagements by network (24h): News: XXXXX Reddit: XXXXX TikTok: XXXXXX X: XXXXXXX YouTube: XXXXXX
Mentions: XXXXX (24h)
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX -XX%
X Months: XXXXXXX +155%
X Year: XXXXXXX +80%
1-Year High: XXXXX on 2025-07-08
1-Year Low: XXX on 2025-01-27
Mentions by network (24h): News: XXX Reddit: XXX TikTok: XXXXX X: XXXXX YouTube: XXX
Creators: XXX (24h)
XXX unique social accounts have posts mentioning Eli Lilly and Company (LLY) in the last XX hours which is down XX% from XXXXX in the previous XX hours
Daily Average: XXXXX
X Week: XXXXX -XXXX%
X Month: XXXXX -XX%
X Months: XXXXXX +285%
X Year: XXXXXX +288%
1-Year High: XXXXX on 2025-07-08
1-Year Low: XXX on 2025-01-27
The most influential creators that mention Eli Lilly and Company in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @ripster47 | X | XXXXXXX | X | XXXXXX |
| @der.aktionaer | X | XXXXXXX | X | XXXXXX |
| @SiemprePulpo | X | XXXXX | X | XXXXXX |
| @doepke_michel | X | XXXXX | X | XXXXXX |
| @mycompanionbox | X | XXXXX | X | XXXXX |
| @EliteGainzTrade | X | XXXXXX | X | XXXXX |
| @seedy19tron | X | XXXXX | X | XXXXX |
| @semodough | X | XXXXXX | X | XXXXX |
| @c2412345 | X | XXX | X | XXXXX |
| @bioinvestor24 | XX | XXXXX | XX | XXXXX |
Sentiment: XX%
Current Value: XX%
Daily Average: XX%
X Week: XX% no change
X Month: XX% +34%
X Months: XX% +9%
X Year: XX% +9%
1-Year High: XX% on 2025-07-08
1-Year Low: XX% on 2025-11-12
Most Supportive Themes:
- Weight Loss Drug Success: (50%) Eli Lilly's Mounjaro and Zepbound are experiencing high demand, with potential for oral formulations.
- AI-Driven Drug Discovery: (30%) Eli Lilly is leveraging AI for accelerating drug discovery processes through partnerships.
- India Investment: (20%) Eli Lilly is expanding its manufacturing and supply chain operations in India.
Most Critical Themes:
- Market Competition: (60%) Eli Lilly faces intense competition in the weight loss drug market from companies like Novo Nordisk.
- Mounjaro Price Increase: (40%) Concerns exist regarding the increasing price of Mounjaro, potentially impacting accessibility and affordability.
Social Dominance: XXXXX%
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.129%
X Month: XXXXX% -XXXXX%
X Months: XXXXX% +0.106%
X Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-07-08
1-Year Low: XXXXX% on 2025-09-14
Market Dominance: XXXX%
Current Value: XXXX%
Daily Average: XX%
1-Year High: XXXXX% on 2025-11-26
1-Year Low: XXXX% on 2025-12-13
Market Cap: $XXXXXXXXXXXXXXX
Current Value: $XXXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXXX +$1.50%
X Month: $XXXXXXXXXXXXXXX +$0.45%
X Months: $XXXXXXXXXXXXXXX +$27%
X Year: $XXXXXXXXXXXXXXX +$30%
1-Year High: $XXXXXXXXXXXXXXX on 2025-11-25
1-Year Low: $XXXXXXXXXXXXXXX on 2025-08-08
UnitedHealth Group
UnitedHealth Group Luigi Mangione is in court today for the murder trial of UnitedHealth CEO Brian Thompson, while news emerges of UnitedHealth's role in the opioid crisis and potential AI-driven coverage denials.
Price: $XXXXXX
Despite negative news and legal challenges, UNH stock shows resilience, potentially due to positive analyst outlooks and a general market uptrend, though it has seen a slight decrease in price over the last XX hours.
24-Hour: XXXX% 7-Day: XXXX% 30-Day: XXXX%
1-Year High: $XXXXXX on 2025-04-11
1-Year Low: $XXXXXX on 2025-08-01
AltRank: XXX
UnitedHealth Group (UNH) is currently AltRank #361 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX -X
X Month: XXX +177
X Months: XXX -XX
X Year: XXX +234
1-Year High: XXXXX on 2025-07-02
1-Year Low: X on 2024-12-29
Galaxy Score: XXXXX
Current Value: XXXXX
Daily Average: XX
X Week: XX +7
X Month: XX -XX
X Months: XX +29
X Year: XX +15
1-Year High: XX on 2025-03-03
1-Year Low: XX on 2025-01-26
Engagements: XXXXXXX (24h)
Current Value: XXXXXXX
Daily Average: XXXXXXXXX
X Week: XXXXXXXXXX +551%
X Month: XXXXXXXXXX -XX%
X Months: XXXXXXXXXXX +57%
X Year: XXXXXXXXXXX +135%
1-Year High: XXXXXXXXXX on 2025-05-15
1-Year Low: XXXXXX on 2025-03-30
Engagements by network (24h): News: XXXXX Reddit: XXXXX TikTok: XXXXXX X: XXXXXXX YouTube: XXXXXX
Mentions: XXXXX (24h)
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX -XX%
X Months: XXXXXXX +8.10%
X Year: XXXXXXX +40%
1-Year High: XXXXX on 2025-08-15
1-Year Low: XXX on 2025-01-27
Mentions by network (24h): News: XXX Reddit: XXX TikTok: XXXXX X: XXXXX YouTube: XXX
Creators: XXX (24h)
XXX unique social accounts have posts mentioning UnitedHealth Group (UNH) in the last XX hours which is down XX% from XXX in the previous XX hours
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXX -XX%
X Months: XXXXXX -XXXX%
X Year: XXXXXXX +33%
1-Year High: XXXXX on 2025-07-03
1-Year Low: XXX on 2025-01-27
The most influential creators that mention UnitedHealth Group in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @TheLongInvest | X | XXXXXXX | X | XXXXXXX |
| @TheRonnieVShow | X | XXXXXX | X | XXXXXX |
| @LeverageShares | X | XXXXXX | X | XXXXXX |
| @TheValueTrade | X | XXXXXX | X | XXXXX |
| @thexcapitalist | X | XXXXXXX | X | XXXXX |
| @BeatTheInsider | X | XXXXXX | X | XXXXX |
| @MrMikeInvesting | X | XXXXXXX | X | XXXXX |
| @twinsight_x | X | XXXXXX | X | XXXXX |
| @EACinvestor | X | XXXXX | X | XXXXX |
| @dailymail | XX | XXXXXXXXXX | X | XXXXX |
Sentiment: XX%
Current Value: XX%
Daily Average: XX%
X Week: XX% +2%
X Month: XX% +2%
X Months: XX% +6%
X Year: XX% +24%
1-Year High: XX% on 2025-11-28
1-Year Low: XX% on 2025-05-15
Most Supportive Themes:
- Positive Price Targets and Valuations: (30%) Analysts and investors express bullish sentiment on UnitedHealth Group, highlighting positive price targets and undervalued status.
- Insider Activity and Investment: (25%) Reports of significant insider buying and increased positions by major investment firms suggest confidence in the company's future performance.
- Strategic Business Moves: (20%) News regarding UnitedHealth Group's business strategies, such as the sale of its South American business and focus on AI, are being discussed.
Most Critical Themes:
- Legal Issues and Lawsuits: (40%) Allegations of using faulty AI to deny patient coverage and ongoing lawsuits are creating negative sentiment and concern.
- Medicare Advantage Changes: (35%) The decision to drop a significant number of seniors from Medicare Advantage plans is drawing criticism and raising questions about the company's practices.
- CEO Assassination Aftermath: (25%) Ongoing legal proceedings and discussions surrounding the assassination of the former CEO continue to be a point of public interest and scrutiny.
Social Dominance: XXXXX%
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.05%
X Month: XXXXX% -XXXXXX%
X Months: XXXXX% +0.029%
X Year: XXXXX% -XXXXX%
1-Year High: XXXX% on 2025-08-15
1-Year Low: XXXXX% on 2025-03-30
Market Dominance: XXXX%
Current Value: XXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-04-01
1-Year Low: XXXXX% on 2025-08-04
Market Cap: $XXXXXXXXXXXXXXX
Current Value: $XXXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXXX +$3.20%
X Month: $XXXXXXXXXXXXXXX +$0.82%
X Months: $XXXXXXXXXXXXXXX +$8.90%
X Year: $XXXXXXXXXXXXXXX -$34%
1-Year High: $XXXXXXXXXXXXXXX on 2025-04-11
1-Year Low: $XXXXXXXXXXXXXXX on 2025-08-01
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. Thermo Fisher Scientific receives analyst upgrades amidst pharma spending boost, but faces a stock price dip post-earnings due to a recent downgrade.
Price: $XXXXXX
The stock price has dipped despite beating earnings expectations, likely due to a recent downgrade by UBS, which has overshadowed positive market cap and social engagement metrics. However, there are also analyst ratings initiating a 'Buy' with a price target of $XXX.
24-Hour: -XXXX% 7-Day: -XXXX% 30-Day: -XXXX%
1-Year High: $XXXXXX on 2025-01-30
1-Year Low: $XXXXXX on 2025-06-17
AltRank: XXX
Thermo Fisher Scientific Inc. (TMO) is currently AltRank #539 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX +9
X Month: XXX +93
X Months: XXX -XXX
X Year: XXX -XX
1-Year High: XXXXX on 2025-08-21
1-Year Low: XX on 2025-07-23
Galaxy Score: XXXXX
Current Value: XXXXX
Daily Average: XX
X Week: XX -XX
X Month: XX -XX
X Months: XX -XX
X Year: XX -XX
1-Year High: XX on 2024-12-31
1-Year Low: XX on 2025-01-01
Engagements: XXXXXX (24h)
Current Value: XXXXXX
Daily Average: XXXXXXX
X Week: XXXXXXX -XX%
X Month: XXXXXXXXX +8.80%
X Months: XXXXXXXXXX +7.20%
X Year: XXXXXXXXXX +105%
1-Year High: XXXXXXXXX on 2025-11-24
1-Year Low: XXXXXX on 2025-03-09
Engagements by network (24h): News: XX Reddit: XXX TikTok: XXXXX X: XXXXXX YouTube: XXXXXX
Mentions: XXX (24h)
Current Value: XXX
Daily Average: XXX
X Week: XXXXX -XX%
X Month: XXXXX -XX%
X Months: XXXXXX -XX%
X Year: XXXXXX +19%
1-Year High: XXXXX on 2024-12-20
1-Year Low: XXX on 2025-09-14
Mentions by network (24h): News: XX Reddit: XXX TikTok: XXX X: XXX YouTube: XXX
Creators: XXX (24h)
XXX unique social accounts have posts mentioning Thermo Fisher Scientific Inc. (TMO) in the last XX hours which is up XX% from XXX in the previous XX hours
Daily Average: XXX
X Week: XXX -XXXX%
X Month: XXXXX -XX%
X Months: XXXXX +7.80%
X Year: XXXXXX +79%
1-Year High: XXXXX on 2024-12-20
1-Year Low: XXX on 2025-01-27
The most influential creators that mention Thermo Fisher Scientific Inc. in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @thermofisher | X | XXXXXXX | XX | XXXXXX |
| @WTCM3 | X | XXXXXX | X | XXXXX |
| @ShohanulI | X | X | X | XXXXX |
| @StockBoxer_AIM | X | XXX | X | XXXXX |
| @fantstockleague | X | XXX | X | XXX |
| @Wahidur39424273 | X | X | XXX | |
| @societyforscience | X | XXXXXX | X | XXX |
| @OptionSkull | X | XXX | X | XXX |
| @localmafi4 | X | X | XXX | |
| @13F_Pro | XX | XXX | X | XXX |
Sentiment: XX%
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% -X%
X Months: XX% +21%
X Year: XX% +10%
1-Year High: XX% on 2025-10-25
1-Year Low: XX% on 2025-05-27
Most Supportive Themes:
- Acquisition of Clario: (40%) Thermo Fisher Scientific is acquiring Clario AI, a clinical trial software company, for approximately $XXX billion, expanding its capabilities in the clinical trial space.
- R&D Expansion in Bengaluru: (25%) Thermo Fisher Scientific has expanded its R&D center in Bengaluru, India, with a significant investment to enhance antibody design, development, and manufacturing capabilities.
- Stock Performance and Analyst Ratings: (20%) Despite beating earnings expectations, Thermo Fisher Scientific's stock price has dipped, though some analysts view it as a world-class compounder.
- Partnerships and Collaborations: (15%) Thermo Fisher Scientific is involved in various collaborations, including an expanded partnership with Harvard Biosciences and support for STEM competitions.
Most Critical Themes:
- Stock Price Dip Post-Earnings: (60%) Thermo Fisher Scientific's stock price has declined despite positive earnings, attributed to a recent downgrade by UBS, overshadowing positive market cap and social engagement metrics.
- Market Dominance Decline: (40%) While social dominance is up, market dominance has seen a slight decrease, indicating a potential shift in market share or investor attention.
Social Dominance: XXXXX%
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.0059%
X Month: XXXXX% +0.051%
X Months: XXXXX% +0.017%
X Year: XXXXX% +0.0006999999999999923%
1-Year High: XXXXX% on 2024-12-20
1-Year Low: XXXX% on 2025-09-14
Market Dominance: XXXX%
Current Value: XXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-12
1-Year Low: XXXXX% on 2025-07-21
Market Cap: $XXXXXXXXXXXXXXX
Current Value: $XXXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXXX -$0.09%
X Month: $XXXXXXXXXXXXXXX -$2.70%
X Months: $XXXXXXXXXXXXXXX +$41%
X Year: $XXXXXXXXXXXXXXX +$8.50%
1-Year High: $XXXXXXXXXXXXXXX on 2025-01-30
1-Year Low: $XXXXXXXXXXXXXXX on 2025-06-17
Abbott Laboratories
Abbott Laboratories Abbott Laboratories (ABT) is seeing increased social media buzz around its Arcblock partnership and AI integration, alongside positive market sentiment. However, concerns linger regarding a recent guidance cut and historical criticisms of baby formula sales.
Price: $XXXXXX
The stock is consolidating near its 52-week low, influenced by negative news and legal issues, though recent positive social media engagement around partnerships may offer some support.
24-Hour: XXXX% 7-Day: XXXX% 30-Day: -XXXX%
1-Year High: $XXXXXX on 2025-03-03
1-Year Low: $XXXXXX on 2025-01-15
AltRank: XXX
Abbott Laboratories (ABT) is currently AltRank #770 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX +392
X Month: XXX +358
X Months: XXX +630
X Year: XXX +478
1-Year High: XXXXX on 2025-06-26
1-Year Low: X on 2025-02-09
Galaxy Score: XXXXX
Current Value: XXXXX
Daily Average: XX
X Week: XX +18
X Month: XX no change
X Months: XX +22
X Year: XX +22
1-Year High: XX on 2025-04-11
1-Year Low: XX on 2025-03-13
Engagements: XXXXXX (24h)
Current Value: XXXXXX
Daily Average: XXXXXXX
X Week: XXXXXX -XX%
X Month: XXXXXXXXX +33%
X Months: XXXXXXXXXX -XX%
X Year: XXXXXXXXXX -XX%
1-Year High: XXXXXXXXX on 2025-01-23
1-Year Low: XXXXX on 2025-12-06
Engagements by network (24h): News: XX Reddit: XXX TikTok: XXXXXX X: XXXXXX YouTube: XXX
Mentions: XXX (24h)
Current Value: XXX
Daily Average: XXX
X Week: XXX -XX%
X Month: XXXXX -XXXX%
X Months: XXXXXX -XX%
X Year: XXXXXX -XX%
1-Year High: XXXXX on 2025-01-23
1-Year Low: XXX on 2025-12-06
Mentions by network (24h): News: X Reddit: XX TikTok: XX X: XXX YouTube: XX
Creators: XXX (24h)
XXX unique social accounts have posts mentioning Abbott Laboratories (ABT) in the last XX hours which is down XX% from XXX in the previous XX hours
Daily Average: XXX
X Week: XXX -XX%
X Month: XXXXX +15%
X Months: XXXXX +47%
X Year: XXXXXX +28%
1-Year High: XXX on 2025-07-18
1-Year Low: XXX on 2025-12-06
The most influential creators that mention Abbott Laboratories in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @MarketCap_Live | X | XXX | X | XXX |
| @ArcBlock_io | X | XXXXXX | X | XXX |
| @ValueSense_io | X | XXXXXX | X | XXX |
| @medtechmd | X | XXX | X | XXX |
| @MarketProphit | X | XXXXXX | X | XXX |
| @NancyCampbelI | X | XXX | X | XX |
| @ks92008 | X | XX | X | XX |
| @PythiaR | X | XXXXXX | X | XX |
| @KathleenHGraham | X | XXX | X | XX |
| @apeviking | XX | XXX | X | XX |
Sentiment: XX%
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XX% on 2025-11-29
1-Year Low: XX% on 2025-12-13
Most Supportive Themes:
- Arcblock Partnership Reveals: (70%) Partnership with Arcblock, a blockchain platform.
- AI and Robotics Integration: (20%) Integration of AI and robotics with decentralized identity.
- Positive Market Sentiment: (10%) Strong bullish sentiment and price increase predictions.
Most Critical Themes:
- Abbott Laboratories Guidance Cut: (60%) Company's reduced 2025 guidance due to tariff threats.
- Baby Formula Sales Criticism: (30%) Historical criticism of baby formula sales practices.
- Legal Challenges: (10%) Ongoing legal challenges, including cases related to NEC baby formula.
Social Dominance: XXXX%
Current Value: XXXX%
Daily Average: XXXX%
X Week: XXXX% +0.0089%
X Month: XXXX% -XXXXX%
X Months: XXXX% -XXXX%
X Year: XXXX% -XXXXX%
1-Year High: XXXXX% on 2025-01-23
1-Year Low: XXXXX% on 2025-12-06
Market Dominance: XXXXX%
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-12
1-Year Low: XXXXX% on 2025-12-09
Market Cap: $XXXXXXXXXXXXXXX
Current Value: $XXXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXXX +$0.24%
X Month: $XXXXXXXXXXXXXXX -$2.60%
X Months: $XXXXXXXXXXXXXXX -$7.50%
X Year: $XXXXXXXXXXXXXXX +$10%
1-Year High: $XXXXXXXXXXXXXXX on 2025-03-03
1-Year Low: $XXXXXXXXXXXXXXX on 2025-01-15
AbbVie Inc
AbbVie Inc AbbVie to present Phase X ECLIPSE data for Atogepant in migraine treatment at the European Headache Congress. Recent social posts highlight investor sentiment and potential M&A activity.
Price: $XXXXXX
Despite positive news and dividend mentions, the stock is trading near a 52-week low, indicating that overvaluation concerns are currently outweighing positive developments, as suggested by the recent price action and social sentiment.
24-Hour: -XXXX% 7-Day: -XXXX% 30-Day: -XXXX%
1-Year High: $XXXXXX on 2025-10-01
1-Year Low: $XXXXXX on 2025-01-22
AltRank: XXX
AbbVie Inc (ABBV) is currently AltRank #595 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX -XXX
X Month: XXX -XXX
X Months: XXX -XXX
X Year: XXX -XXX
1-Year High: XXXXX on 2025-05-14
1-Year Low: X on 2025-04-28
Galaxy Score: XX
Current Value: XX
Daily Average: XX
X Week: XX +6
X Month: XX +25
X Months: XX -X
X Year: XX +6
1-Year High: XX on 2025-05-12
1-Year Low: XX on 2025-02-26
Engagements: XXXXXXX (24h)
Current Value: XXXXXXX
Daily Average: XXXXXXX
X Week: XXXXXXX -XX%
X Month: XXXXXXXXX +16%
X Months: XXXXXXXXXX -XX%
X Year: XXXXXXXXXX -XX%
1-Year High: XXXXXXXXX on 2025-01-26
1-Year Low: XXXXXX on 2025-11-09
Engagements by network (24h): News: XX Reddit: XXX TikTok: XXXXXX X: XXXXXX YouTube: XXXXX
Mentions: XXX (24h)
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX -XXXX%
X Month: XXXXX -XX%
X Months: XXXXXX +56%
X Year: XXXXXX +21%
1-Year High: XXXXX on 2025-07-03
1-Year Low: XXX on 2025-12-07
Mentions by network (24h): News: X Reddit: XXX TikTok: XXX X: XXXXX YouTube: XX
Creators: XXX (24h)
XXX unique social accounts have posts mentioning AbbVie Inc (ABBV) in the last XX hours which is down XX% from XXX in the previous XX hours
Daily Average: XXX
X Week: XXX +1.90%
X Month: XXXXX +14%
X Months: XXXXXX +271%
X Year: XXXXXX +149%
1-Year High: XXXXX on 2025-07-03
1-Year Low: XXX on 2025-12-07
The most influential creators that mention AbbVie Inc in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @abbvie | X | XXXXX | XX | XXXXXX |
| @jfais20 | X | XXXXXX | X | XXXXX |
| @ValueSense_io | X | XXXXXX | X | XXXXX |
| @smithy05261244 | X | XXX | X | XXXXX |
| @Michael16887539 | X | XXX | XX | XXXXX |
| @HOThomasWPhelps | X | XXXXX | X | XXXXX |
| @semodough | X | XXXXXX | X | XXXXX |
| @learnbiotech | X | XXXXX | X | XXX |
| @WallStSai | X | XXXXX | X | XXX |
| @yaireinhorn | XX | XXXXXX | X | XXX |
Sentiment: XX%
Current Value: XX%
Daily Average: XX%
X Week: XX% +12%
X Month: XX% +18%
X Months: XX% +18%
X Year: XX% +10%
1-Year High: XX% on 2025-07-04
1-Year Low: XX% on 2025-08-10
Most Supportive Themes:
- Positive Sentiment and All-Time Highs: (35%) The stock is experiencing strong investor confidence, reflected in positive sentiment and reaching all-time high prices.
- Product and Pipeline Updates: (25%) Positive trial results for upadacitinib and strategic acquisitions like Gilgamesh Pharmaceuticals are driving optimism.
- Dividend and Value: (15%) AbbVie is recognized as a strong dividend stock, attracting investors focused on value and income generation.
Most Critical Themes:
- Overvaluation Concerns: (10%) Some analyses suggest the stock may be overvalued, potentially leading to a future price correction.
- Competition and Market Dynamics: (5%) Competitive pressures from companies like Eli Lilly and Merck, and discussions about market dominance, are noted.
Social Dominance: XXXX%
Current Value: XXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.037%
X Month: XXXXX% +0.01%
X Months: XXXXX% -XXXXX%
X Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-07-04
1-Year Low: XXXXX% on 2025-12-02
Market Dominance: XXXXX%
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-12
1-Year Low: XXXX% on 2025-01-22
Market Cap: $XXXXXXXXXXXXXXX
Current Value: $XXXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXXX -$1.70%
X Month: $XXXXXXXXXXXXXXX -$3.90%
X Months: $XXXXXXXXXXXXXXX +$17%
X Year: $XXXXXXXXXXXXXXX +$29%
1-Year High: $XXXXXXXXXXXXXXX on 2025-10-01
1-Year Low: $XXXXXXXXXXXXXXX on 2025-01-22
Novo-Nordisk
Novo-Nordisk Novo Nordisk launches Ozempic in India, while analysts express concerns about shrinking 2026 revenue due to competition and potential price drops.
Price: $XXXXX
The stock price is showing signs of a potential bottom, influenced by positive social sentiment regarding capital discipline and potential share buybacks, alongside recent positive trial results for Amycretin, despite concerns about competition and market share.
24-Hour: XXX% 7-Day: XXXX% 30-Day: XXXX%
1-Year High: $XXXXXX on 2024-12-16
1-Year Low: $XX on 2025-11-24
AltRank: XXX
Novo-Nordisk (NVO) is currently AltRank #398 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX +87
X Month: XXX +78
X Months: XXX -XXXXX
X Year: XXX +13
1-Year High: XXXXX on 2025-07-17
1-Year Low: X on 2025-06-10
Galaxy Score: XXXXX
Current Value: XXXXX
Daily Average: XX
X Week: XX +2
X Month: XX +7
X Months: XX -XX
X Year: XX +23
1-Year High: XX on 2025-06-10
1-Year Low: XX on 2025-01-03
Engagements: XXXXXXX (24h)
Current Value: XXXXXXX
Daily Average: XXXXXXX
X Week: XXXXXXXXX +4.20%
X Month: XXXXXXXXXX -XX%
X Months: XXXXXXXXXXX +118%
X Year: XXXXXXXXXXX +212%
1-Year High: XXXXXXXXX on 2025-11-02
1-Year Low: XXXXXX on 2025-01-05
Engagements by network (24h): Reddit: XXXXX TikTok: XXXXX X: XXXXXXX YouTube: XXXXXX
Mentions: XXXXX (24h)
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX -XX%
X Months: XXXXXX +89%
X Year: XXXXXX +130%
1-Year High: XXXXX on 2025-11-07
1-Year Low: XXX on 2025-03-01
Mentions by network (24h): Reddit: XXX TikTok: XXX X: XXXXXX YouTube: XXX
Creators: XXX (24h)
XXX unique social accounts have posts mentioning Novo-Nordisk (NVO) in the last XX hours which is up XXXX% from XXX in the previous XX hours
Daily Average: XXX
X Week: XXXXX -XXXX%
X Month: XXXXX -XX%
X Months: XXXXXX +113%
X Year: XXXXXX +147%
1-Year High: XXXXX on 2025-11-07
1-Year Low: XXX on 2025-01-27
The most influential creators that mention Novo-Nordisk in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @semodough | X | XXXXXX | X | XXXXXX |
| @SixSigmaCapital | X | XXXXXX | X | XXXXXX |
| @otvodisha | X | XXXXXXXXXX | X | XXXXXX |
| @TacticzH | X | XXXXXX | XX | XXXXXX |
| @MrMikeInvesting | X | XXXXXXX | X | XXXXXX |
| @SiemprePulpo | X | XXXXX | X | XXXXXX |
| @investseekers | X | XXXXX | XX | XXXXXX |
| @bdinvestingg | X | XXXXX | X | XXXXXX |
| @DeepIceValue | X | XXXXXX | XX | XXXXXX |
| @doepke_michel | XX | XXXXX | X | XXXXXX |
Sentiment: XX%
Current Value: XX%
Daily Average: XX%
X Week: XX% +4%
X Month: XX% -X%
X Months: XX% +4%
X Year: XX% +8%
1-Year High: XX% on 2025-11-02
1-Year Low: XX% on 2025-06-23
Most Supportive Themes:
- Positive Clinical Trial Results and Wegovy's Cardiovascular Benefits: (35%) Posts highlighting positive results from clinical trials for Novo Nordisk's drugs, particularly Wegovy, and its cardiovascular benefits.
- Long-Term Growth Potential and Valuation: (25%) Posts discussing the long-term growth potential of Novo Nordisk, especially in the obesity and diabetes markets, and its current valuation.
- Expert Analysis and Recommendations: (15%) Posts from analysts and financial experts recommending Novo Nordisk as a buy or highlighting its strengths.
Most Critical Themes:
- Competition and Market Share Concerns: (20%) Posts expressing concerns about increasing competition from other pharmaceutical companies, particularly Eli Lilly, and its impact on Novo Nordisk's market share.
- Negative Guidance and Restructuring: (5%) Posts discussing the company's lowered sales and operating profit outlook, job cuts, and restructuring efforts.
Social Dominance: XXXXX%
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXX% +0.39%
X Month: XXXXX% +0.071%
X Months: XXXXX% +0.245%
X Year: XXXXX% +0.159%
1-Year High: XXXXX% on 2024-12-22
1-Year Low: XXXX% on 2025-03-23
Market Dominance: XXXX%
Current Value: XXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXX% on 2025-11-10
Market Cap: $XXXXXXXXXXXXXXX
Current Value: $XXXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXXX +$5.10%
X Month: $XXXXXXXXXXXXXXX +$2.10%
X Months: $XXXXXXXXXXXXXXX -$35%
X Year: $XXXXXXXXXXXXXXX -$53%
1-Year High: $XXXXXXXXXXXXXXX on 2024-12-16
1-Year Low: $XXXXXXXXXXXXXXX on 2025-11-24
AstraZeneca PLC
AstraZeneca PLC AstraZeneca is collaborating with Tempus AI on a new oncology AI foundation model, while also facing scrutiny from the US FDA regarding RSV therapies for infants.
Price: $XXXXX
AstraZeneca's stock is experiencing an upward trend, hitting a 52-week and all-time high, driven by strong Q3 earnings, positive analyst outlooks, and recent social media buzz highlighting strong free cash flow projections, despite ongoing discussions about past vaccine side effects.
24-Hour: -XXXX% 7-Day: -XXXX% 30-Day: XXXX%
1-Year High: $XXXXX on 2025-11-26
1-Year Low: $XXXXX on 2024-12-19
AltRank: XXX
AstraZeneca PLC (AZN) is currently AltRank #489 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX +390
X Month: XXX -XXX
X Months: XXX -XXXXX
X Year: XXX -XXX
1-Year High: XXXXX on 2025-05-08
1-Year Low: X on 2025-07-29
Galaxy Score: XXXXX
Current Value: XXXXX
Daily Average: XX
X Week: XX +20
X Month: XX +3
X Months: XX -X
X Year: XX +19
1-Year High: XX on 2025-02-12
1-Year Low: XX on 2025-06-29
Engagements: XXXXXXX (24h)
Current Value: XXXXXXX
Daily Average: XXXXXX
X Week: XXXXXXXXX +23%
X Month: XXXXXXXXX +19%
X Months: XXXXXXXXXX +172%
X Year: XXXXXXXXXX +45%
1-Year High: XXXXXXXXX on 2025-11-01
1-Year Low: XXXXX on 2025-01-26
Engagements by network (24h): News: XX Reddit: XXXXX TikTok: XXXXXX X: XXXXXX YouTube: XXXXXX
Mentions: XXX (24h)
Current Value: XXX
Daily Average: XXX
X Week: XXXXX -XX%
X Month: XXXXX +3.10%
X Months: XXXXXX +65%
X Year: XXXXXX -XXXX%
1-Year High: XXXXX on 2025-03-13
1-Year Low: XX on 2025-01-27
Mentions by network (24h): News: XX Reddit: XXX TikTok: XXXXX X: XXXXX YouTube: XXX
Creators: XXX (24h)
XXX unique social accounts have posts mentioning AstraZeneca PLC (AZN) in the last XX hours which is down XX% from XXX in the previous XX hours
Daily Average: XXX
X Week: XXXXX -XX%
X Month: XXXXX -XX%
X Months: XXXXXX +89%
X Year: XXXXXX -XX%
1-Year High: XXX on 2025-11-10
1-Year Low: XX on 2025-01-27
The most influential creators that mention AstraZeneca PLC in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @astrazenecagermany | X | XXX | X | XXXXXX |
| @semodough | X | XXXXXX | X | XXXXXX |
| @JacobPlieth | X | XXXXXX | X | XXXXX |
| @WallStSai | X | XXXXX | X | XXXXX |
| @bioinvestor24 | X | XXXXX | X | XXXXX |
| @pharmalot | X | XXXXXX | X | XXX |
| @scientificamerican | X | XXXXXXX | X | XXX |
| @MethOSilly | X | XX | X | XXX |
| @mohdhafiz.abdullah | X | X | X | XXX |
| @grok | XX | XXXXXXXXX | XX | XXX |
Sentiment: XX%
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% -X%
X Months: XX% +10%
X Year: XX% +3%
1-Year High: XX% on 2025-03-19
1-Year Low: XX% on 2025-11-01
Most Supportive Themes:
- Oncology and Biopharma Prospects: (25%) Analysts have upgraded their outlook on AstraZeneca's performance in the oncology and biopharmaceutical sectors.
- Clinical Trial Successes: (20%) Positive outcomes from clinical trials, especially in areas like breast cancer treatment, are contributing to a favorable sentiment.
Most Critical Themes:
- UK Investment Concerns: (40%) Concerns exist regarding AstraZeneca's investments in the UK and potential changes to stock market listings, creating uncertainty.
- COVID-19 Vaccine Side Effects: (35%) Past acknowledgments of rare side effects associated with the COVID-19 vaccine continue to be a subject of discussion and criticism.
Social Dominance: XXXXX%
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.134%
X Month: XXXXX% +0.071%
X Months: XXXXX% +0.123%
X Year: XXXXX% +0.037%
1-Year High: XXXXX% on 2025-03-13
1-Year Low: XXXXX% on 2025-09-21
Market Dominance: XXXXX%
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-12
1-Year Low: XXXXX% on 2025-07-21
Market Cap: $XXXXXXXXXXXXXXX
Current Value: $XXXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXXX -$0.34%
X Month: $XXXXXXXXXXXXXXX +$1.40%
X Months: $XXXXXXXXXXXXXXX +$22%
X Year: $XXXXXXXXXXXXXXX +$35%
1-Year High: $XXXXXXXXXXXXXXX on 2025-11-26
1-Year Low: $XXXXXXXXXXXXXXX on 2024-12-19
Novartis AG
Novartis AG Novartis AG is making a significant $XX billion investment in US manufacturing, aiming to produce all key medicines domestically. This move strengthens its presence and supply chain within the United States.
Price: $XXXXXX
The stock price is experiencing downward pressure, likely due to Q3 earnings that missed expectations, despite the positive news of the Avidity Biosciences acquisition. The market may be weighing the substantial investment against current financial performance.
24-Hour: XXXX% 7-Day: -XXXX% 30-Day: X%
1-Year High: $XXXXXX on 2025-12-03
1-Year Low: $XXXXX on 2024-12-19
AltRank: XXX
Novartis AG (NVS) is currently AltRank #615 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX +15
X Month: XXX -XXX
X Months: XXX -XXX
X Year: XXX -XXX
1-Year High: XXXXX on 2025-02-18
1-Year Low: XX on 2025-11-21
Galaxy Score: XXXXX
Current Value: XXXXX
Daily Average: XX
X Week: XX +9
X Month: XX +5
X Months: XX +30
X Year: XX +22
1-Year High: XX on 2025-05-20
1-Year Low: XX on 2025-01-09
Engagements: XXXXXX (24h)
Current Value: XXXXXX
Daily Average: XXXXXXX
X Week: XXXXXXXXX +438%
X Month: XXXXXXXXXX +99%
X Months: XXXXXXXXXX +170%
X Year: XXXXXXXXXX +177%
1-Year High: XXXXXXXXX on 2025-11-27
1-Year Low: XXXXXX on 2025-01-07
Engagements by network (24h): News: XX Reddit: XXXXX TikTok: XXXXXX X: XXXXXX YouTube: XXXXX
Mentions: XXX (24h)
Current Value: XXX
Daily Average: XXX
X Week: XXXXX +0.38%
X Month: XXXXX -XX%
X Months: XXXXXX +34%
X Year: XXXXXX +196%
1-Year High: XXXXX on 2025-10-27
1-Year Low: XXX on 2024-12-25
Mentions by network (24h): News: X Reddit: XXX TikTok: XXX X: XXXXX YouTube: XXX
Creators: XXX (24h)
XXX unique social accounts have posts mentioning Novartis AG (NVS) in the last XX hours which is down XX% from XXX in the previous XX hours
Daily Average: XXX
X Week: XXX +1.50%
X Month: XXXXX -XXXX%
X Months: XXXXX +28%
X Year: XXXXXX +191%
1-Year High: XXX on 2025-10-27
1-Year Low: XXX on 2024-12-25
The most influential creators that mention Novartis AG in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @business | X | XXXXXXXXX | X | XXXXXX |
| @Darwin_Knows | X | XXX | XX | XXXXX |
| @stats_feed | X | XXXXXXXXX | X | XXXXX |
| @ThePlayersTV | X | XXXXX | X | XXX |
| @ABC11_WTVD | X | XXXXXXX | X | XXX |
| @novartis | X | XXXXXX | X | XXX |
| @NovartisUS | X | XXXXX | X | XXX |
| @whoisstaciejones | X | XXX | X | XXX |
| @novartiscareers | X | XXXXX | X | XXX |
| @grok | XX | XXXXXXXXX | XX | XXX |
Sentiment: XX%
Current Value: XX%
Daily Average: XX%
X Week: XX% +7%
X Month: XX% +1%
X Months: XX% +11%
X Year: XX% +8%
1-Year High: XX% on 2025-10-26
1-Year Low: XX% on 2025-11-26
Most Supportive Themes:
- Acquisition of Avidity Biosciences: (70%) Novartis AG is acquiring Avidity Biosciences for $XX billion, strengthening its neuroscience pipeline.
- Pipeline Advancements: (10%) Novartis AG is presenting new treatments, including for Sjogren's disease, and has advanced its RNA therapeutics.
- Positive Financial Performance: (20%) Novartis AG reported solid sales and core operating income growth in Q3 2025, driven by new cancer medicines.
Most Critical Themes:
- Drug Pricing and Access Concerns: (60%) There are discussions and concerns regarding the pricing of Novartis's drug Pluvicto and patient access programs.
- Past Legal Issues: (40%) Novartis AG has faced past settlements related to kickbacks and co-pay fraud.
Social Dominance: XXXXX%
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.039%
X Month: XXXXX% +0.031%
X Months: XXXXX% +0.035%
X Year: XXXXX% +0.045%
1-Year High: XXXX% on 2025-04-12
1-Year Low: XXXXX% on 2025-07-01
Market Dominance: XXXXX%
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXX% on 2025-03-31
1-Year Low: XXXXX% on 2024-12-16
Market Cap: $XXXXXXXXXXXXXXX
Current Value: $XXXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXXX +$0.31%
X Month: $XXXXXXXXXXXXXXX +$0.21%
X Months: $XXXXXXXXXXXXXXX +$7.80%
X Year: $XXXXXXXXXXXXXXX +$29%
1-Year High: $XXXXXXXXXXXXXXX on 2025-12-03
1-Year Low: $XXXXXXXXXXXXXXX on 2024-12-19
Merck & Co., Inc.
Merck & Co., Inc. FDA launches new safety review for infant RSV therapies while also approving Merck's drug for cattle to combat screwworm.
Price: $XXXXXX
The stock price is experiencing a positive trend, driven by recent analyst upgrades and positive news regarding Keytruda's subcutaneous formulation approval and acquisition of Cidara Therapeutics, outweighing concerns about Keytruda's loss of exclusivity and UK investment cuts.
24-Hour: XXXX% 7-Day: XXXX% 30-Day: XXXX%
1-Year High: $XXXXXX on 2025-11-25
1-Year Low: $XXXXX on 2025-05-14
AltRank: XXX
Merck & Co., Inc. (MRK) is currently AltRank #488 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX -XX
X Month: XXX -XX
X Months: XXX -XXX
X Year: XXX -XX
1-Year High: XXXXX on 2025-05-06
1-Year Low: X on 2024-12-19
Galaxy Score: XXXXX
Current Value: XXXXX
Daily Average: XX
X Week: XX +11
X Month: XX +6
X Months: XX -X
X Year: XX +8
1-Year High: XX on 2025-04-07
1-Year Low: XX on 2024-12-27
Engagements: XXXXXXX (24h)
Current Value: XXXXXXX
Daily Average: XXXXXXX
X Week: XXXXXXXXX +4.20%
X Month: XXXXXXXXXX -XX%
X Months: XXXXXXXXXX -XXXX%
X Year: XXXXXXXXXXX +15%
1-Year High: XXXXXXXXXX on 2025-11-11
1-Year Low: XXXXXXX on 2025-03-22
Engagements by network (24h): News: XX Reddit: XXXXXX TikTok: XXXXXX X: XXXXXX YouTube: XXXXXX
Mentions: XXX (24h)
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX -XX%
X Months: XXXXXXX +172%
X Year: XXXXXXX +124%
1-Year High: XXXXX on 2025-07-03
1-Year Low: XXX on 2025-01-27
Mentions by network (24h): News: XX Reddit: XXX TikTok: XXX X: XXXXX YouTube: XXX
Creators: XXX (24h)
XXX unique social accounts have posts mentioning Merck & Co., Inc. (MRK) in the last XX hours which is down XX% from XXX in the previous XX hours
Daily Average: XXX
X Week: XXXXX -XX%
X Month: XXXXX -XX%
X Months: XXXXXX +320%
X Year: XXXXXX +329%
1-Year High: XXXXX on 2025-07-03
1-Year Low: XXX on 2025-12-07
The most influential creators that mention Merck & Co., Inc. in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @christianmerckvideos | X | XXXXXXX | XX | XXXXXX |
| @grok | X | XXXXXXXXX | XX | XXXXXX |
| @Not_so_ghetto | X | XXXXXXX | X | XXXXXX |
| @NicHulscher | X | XXXXXXX | X | XXXXXX |
| @SuperDuperInvst | X | XXXXXX | X | XXXXX |
| @smithy05261244 | X | XXX | X | XXXXX |
| @bullishbruk | X | XXXXX | X | XXXXX |
| @merckindonesia | X | XXXXX | X | XXXXX |
| @UC5TLNA7LjEbMnt2NIHU4KRA | X | XX | XX | XXXXX |
| @ftystudios1 | XX | XXXXXXX | X | XXXXX |
Sentiment: XX%
Current Value: XX%
Daily Average: XX%
X Week: XX% +7%
X Month: XX% +9%
X Months: XX% +8%
X Year: XX% +17%
1-Year High: XX% on 2025-11-11
1-Year Low: XX% on 2025-01-02
Most Supportive Themes:
- Keytruda Approval and Subcutaneous Formulation: (25%) Positive sentiment surrounding the FDA approval of Keytruda's new subcutaneous formulation, offering more convenient administration.
- Merck Foundation Initiatives: (15%) Appreciation for Merck Foundation's programs focused on healthcare capacity, girl education, and women's empowerment.
Most Critical Themes:
- UK Investment Cuts: (30%) Concerns over Merck's decision to scrap a UK research facility and reduce investments due to unfavorable policies.
- Vaccine Safety Concerns: (20%) Criticism and skepticism regarding vaccine safety, particularly the HPV vaccine Gardasil, and alleged suppression of data.
Social Dominance: XXXXX%
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.112%
X Month: XXXXX% -XXXXX%
X Months: XXXXX% +0.047%
X Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-07-07
1-Year Low: XXXXX% on 2025-12-07
Market Dominance: XXXX%
Current Value: XXXX%
Daily Average: X%
1-Year High: XXXX% on 2025-03-10
1-Year Low: XXXXX% on 2025-05-08
Market Cap: $XXXXXXXXXXXXXXX
Current Value: $XXXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXXX +$0.22%
X Month: $XXXXXXXXXXXXXXX +$7.90%
X Months: $XXXXXXXXXXXXXXX +$22%
X Year: $XXXXXXXXXXXXXXX -$3.50%
1-Year High: $XXXXXXXXXXXXXXX on 2025-11-25
1-Year Low: $XXXXXXXXXXXXXXX on 2025-05-14
Healthcare
KuCoin lists $BBT, driving significant engagement and price action discussions. Meanwhile, $HSAI gains traction in the autonomous vehicle and robotics sectors, highlighted by Morgan Stanley's inclusion in their Humanoid Tech list.
About Healthcare
This topic covers discussions on healthcare-related stocks, tokens, and the integration of blockchain and AI within the healthcare sector.
Insights
- Healthcare posts created is up XXXXX% from the previous week.
Engagements: XXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
X Week: XXXXXX -XX%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX -XX%
X Year: XXXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-01-06
1-Year Low: XXXXX on 2025-12-06
Engagements by network (24h): Reddit: X TikTok: X X: XXXXX YouTube: X
Mentions: XXX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXX -XX%
X Month: XXXXX +43%
X Months: XXXXXXX +61%
X Year: XXXXXXX +2,057%
1-Year High: XXXXX on 2025-06-29
1-Year Low: XXX on 2025-10-12
Mentions by network (24h): Reddit: X TikTok: X X: XXX YouTube: X
Creators: XXX (24h)
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Healthcare in the last XX hours which is down XX% from XXX in the previous XX hours
Daily Average: XXX
X Week: XXX -XX%
X Month: XXX +17%
X Months: XXXXXXX +72%
X Year: XXXXXXX +4,697%
1-Year High: XXXXX on 2025-06-29
1-Year Low: XX on 2025-10-12
The most influential creators that mention Healthcare in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @kucoincom | X | XXXXXXXXX | X | XXXXX |
| @DyorNetScans | X | XX | XX | XXX |
| @GaleonCare | X | XXXXXX | XX | XXX |
| @aicryptopattern | X | XXXXX | X | XXX |
| @BBT_token | X | XXXXXXX | X | XXX |
| @CML_Crypto | X | XXXXXX | X | XX |
| @desciatoms | X | XXX | X | XX |
| @Cryptophory | X | XXXXX | X | XX |
| @tuum_io | X | XXXXXX | X | XX |
| @ID_OL7 | XX | XXXXX | X | XX |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XX% on 2025-07-06
1-Year Low: XX% on 2025-12-02
Most Supportive Themes:
- AI and Autonomous Vehicles: (60%) Advancements in AI and autonomous vehicle technology are driving significant interest and positive sentiment within the healthcare sector.
- Family and Community Support: (30%) $BBT is gaining traction for its focus on supporting families and communities, highlighting its role in social impact initiatives.
- Decentralized Healthcare: (10%) Galeon (GALEON) is noted for its efforts in building decentralized healthcare infrastructure, including hospitals and patient data ecosystems.
Most Critical Themes:
Top Healthcare Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"DCN isnt just a token it powers a full commerce ecosystem. Every sale task and business action inside the platform uses $DCN. More activity = higher demand = stronger value. Join the airdrop now: More platform updates coming in days. #DCN #Airdrop"
X Link @DCN_Community 2025-12-12T22:40Z XXX followers, XXX engagements
"$HPO Guys Don't miss the Target price for Next Week. 💥📢"
X Link @PMohalder53311 2025-12-12T20:29Z XX followers, X engagements
"Added today: $FLYBNB $WEALTH $LUNC $CALVIN $BBT $SOLYMPICS $RAVE $MICKEY $WEB $DIABLO"
X Link @CryptoFonts 2025-12-12T17:20Z XXX followers, XXX engagements
"✨ Recently Listed Coins to CryptoRank: $SUSDS sUSDS $BTX BeatSwap $US Talus Network $BBT Burger Blast Token $ALMANAK Almanak $TONO Tonomy $OEX OracleX $CYS Cysic $CLONE Confidential Layer $KYO Kyo Finance $hyperRAM xRAM LST $MOMO MOMO $ $ADI ADI Chain $ICE ICE #Crypto"
X Link @aicryptopattern 2025-12-12T15:31Z 5640 followers, XXX engagements
Healthcare UnitedHealth Group faces a significant stock drop following CEO departure and suspended financial outlook due to rising medical costs. Pfizer initiates a lawsuit against Metsera and Novo Nordisk, signaling a competitive clash in the drug market.
Creators: XXXXX
XXXXX unique social accounts have posts mentioning Healthcare in the last XX hours which is down XX% from XXXXXX in the previous XX hours
Daily Average: XXXXXX
X Week: XXXXXX -X%
X Month: XXXXXX -XX%
X Months: XXXXXXX +105%
X Year: XXXXXXX +44%
1-Year High: XXXXXX on 2025-06-28
1-Year Low: XXXXX on 2025-01-27
The most influential creators that mention Healthcare in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @cybervillagesolution | X | XXXXXXXXXX | XX | XXXXXXXXX |
| @cocorockstarr | X | XXXXXX | X | XXXXXXXXX |
| @cvs | X | XXXXXX | XX | XXXXXXXXX |
| @thekrazycouponlady | X | XXXXXXX | X | XXXXXXX |
| @hiuenglish | X | XXXXXXXXX | X | XXXXXXX |
| @TheLongInvest | X | XXXXXXX | XX | XXXXXXX |
| @sanofi | X | XXXXXX | XX | XXXXXX |
| @StockMKTNewz | X | XXXXXXX | XX | XXXXXX |
| @mohinispeaks | X | XXXXXX | X | XXXXXX |
| @christianmerckvideos | XX | XXXXXXX | XX | XXXXXX |
Sentiment: XX%
Current Value: XX%
Daily Average: XX%
X Week: XX% +2%
X Month: XX% +11%
X Months: XX% +39%
X Year: XX% +30%
1-Year High: XX% on 2025-11-02
1-Year Low: XX% on 2025-06-14
Most Supportive Themes:
- Increased Engagement: (30%) Healthcare engagements have seen a significant increase of XXXXXX% from the previous week, indicating growing interest.
- Creator Activity: (10%) There's a notable increase in healthcare creators, up XXXX% from the previous week.
- Positive Sentiment: (60%) The overall sentiment for healthcare is positive, with a current value of 85%.
Most Critical Themes:
- UnitedHealth Group CEO Departure and Financial Outlook Suspension: (70%) UnitedHealth Group's CEO is stepping down, and the company has suspended its 2025 financial outlook due to higher-than-expected medical costs, leading to a significant drop in stock value.
- Pfizer Lawsuit Against Metsera and Novo Nordisk: (30%) Pfizer has filed a lawsuit against Metsera and Novo Nordisk over a merger dispute, indicating potential antitrust concerns and a competitive battle in the drug market.
Stocks Lululemon CEO Calvin McDonald is stepping down amidst sales decline in North America, while Broadcom stock drops significantly after earnings report due to AI payoff fears.
Creators: XXXXXXX
XXXXXXX unique social accounts have posts mentioning Stocks in the last XX hours which is down XXXX% from XXXXXXX in the previous XX hours
Daily Average: XXXXXXX
X Week: XXXXXXX -XX%
X Month: XXXXXXXXX -XX%
X Months: XXXXXXXXX +68%
X Year: XXXXXXXXXX +72%
1-Year High: XXXXXXX on 2025-07-23
1-Year Low: XXXXXXX on 2025-01-27
The most influential creators that mention Stocks in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| X | XXXXXXXXXX | XXX | XXXXXXXXXX | |
| @Supermicro | X | XXXXXX | XX | XXXXXXXXXX |
| @motorolaindiain | X | XXXXXXXXX | XX | XXXXXXXXXX |
| @mastercard | X | XXXXXXX | XX | XXXXXXXXXX |
| @tiktok | X | XXXXXXXXXX | X | XXXXXXXXXX |
| @walmart | X | XXXXXXX | XX | XXXXXXXXXX |
| @fixy | X | XXXXXXX | XX | XXXXXXXXX |
| @hardwarenf | X | XXXXXX | XX | XXXXXXXXX |
| @spotifyindia91 | X | XXXXXXX | XX | XXXXXXXXX |
| @zeaplanet | XX | XXXXXX | X | XXXXXXXXX |
Sentiment: XX%
Current Value: XX%
Daily Average: XX%
X Week: XX% no change
X Month: XX% -X%
X Months: XX% +8%
X Year: XX% +11%
1-Year High: XX% on 2025-11-13
1-Year Low: XX% on 2025-03-19
Most Supportive Themes:
- AI and Technology Advancements: (30%) Discussions around AI development, new AI models, and hardware like NVIDIA chips are driving significant engagement.
- Electric Vehicles and Automotive Industry: (25%) News and discussions about Tesla, its performance, and comparisons with other automotive brands are prominent.
- Consumer Goods and Retail: (20%) Mentions of major retailers like Walmart and brands such as Coca-Cola and Starbucks, along with their promotions and services, are frequent.
Most Critical Themes:
- Market Volatility and Economic Factors: (40%) Concerns about market fluctuations, potential rate cuts, and their impact on sectors like private equity are present.
- Company-Specific Challenges: (35%) News regarding specific companies facing issues such as data breaches, product recalls, or earnings disappointments are noted.
- Regulatory and Legal Issues: (25%) Discussions around potential government regulations, legal challenges, and controversial incidents involving companies or individuals are observed.